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The level of intracellular diadenosine 5′, 5′′′-P1,P4-tetraphosphate (Ap4A) increases several fold in 
mammalian cells treated with non-cytotoxic doses of interstrand DNA-crosslinking agents such as 
mitomycin C.  It is also increased in cells lacking DNA repair proteins including XRCC1, PARP1, APTX 
and FANCG, while >50-fold increases (up to around 25 µM) are achieved in repair mutants exposed to 
mitomycin C.  Part of this induced Ap4A is converted into novel derivatives, identified as mono- and di-
ADP-ribosylated Ap4A.  Gene knockout experiments suggest that DNA ligase III is primarily responsible 
for the synthesis of damage-induced Ap4A and that PARP1 and PARP2 can both catalyze its ADP-
ribosylation.  Degradative proteins such as aprataxin may also contribute to the increase.  Using a cell-
free replication system, Ap4A was found to cause a marked inhibition of the initiation of DNA replicons, 
while elongation was unaffected.  Maximum inhibition of 70-80% was achieved with 20 µM Ap4A.  
Ap3A, Ap5A, Gp4G and ADP-ribosylated Ap4A were without effect.  It is proposed that Ap4A acts as an 









1Abbreviations: Ap3A, diadenosine 5′, 5′′′-P1,P3-triphosphate; Ap4A, diadenosine 5′, 5′′′-P1,P4-
tetraphosphate; Ap5A, diadenosine 5′, 5′′′-P1,P5-pentaphosphate; Gp4G, diguanosine 5′, 5′′′-P1,P4-
tetraphosphate; ADPR-Ap4A, ADP-ribosylated diadenosine 5′, 5′′′-P1,P4-tetraphosphate; MEF, mouse 
embryo fibroblast; MMC, mitomycin C; APTX, aprataxin; PARP; poly(ADP)ribose polymerase; SSB, 
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1.  Introduction 
 
The dinucleotide diadenosine-5',5'''-P1,P4-tetraphosphate (Ap4A1, Fig. 1a) is synthesized in 
prokaryotes and eukaryotes in response to a variety of cellular stresses and stimuli and has been described 
as a pleiotropically acting alarmone with a role in establishing the response to these stresses, although few 
molecular details of its actions have ever been established [1-4].  Thus, Ap4A has been implicated in the 
heat shock and DNA damage responses [5-7], apoptosis [8, 9] and in several signalling pathways [10-13].  
Ap4A can be synthesized in vitro by several enzymes including aminoacyl-tRNA synthetases, firefly 
luciferase, DNA and RNA ligases, acyl-CoA synthetases and other ligases [13-15].  Of these, it is 
generally accepted that the aminoacyl-tRNA synthetases are primarily responsible for the steady-state 
level of Ap4A in vivo [16]; however, the precise synthetic source of stress-induced increases may depend 
on the stimulus in question.  In eukaryotes, the principal enzyme responsible for Ap4A degradation is the 
NUDT2 nudix hydrolase [17, 18] although two HIT family proteins, the Fhit tumour suppressor [19] and 
aprataxin (APTX) [20], are also able to hydrolyse Ap4A to some extent. 
With regard to the DNA damage response, evidence gathered several years ago led to the hypothesis 
that DNA damage-induced Ap4A had some role in regulating DNA replication in response to the damage 
[2-4, 21].  This evidence included the increase in Ap4A observed after exposure of cells to DNA 
damaging agents, particularly those that cause single-strand breaks (SSBs) [5, 6, 22] and the ability of 
Ap4A to bind specifically to a protein (still unidentified) associated with a multiprotein complex that 
included DNA polymerase-α/primase [23-25].  Detractors of this notion pointed to the lack of cell 
survival data associated with stress induction and suggested that only unphysiological, lethal stresses 
caused a significant increase in Ap4A through a derangement of normal metabolism [26, 27].  This, plus 
the later recognition of the importance of PI3-type kinases in regulating DNA replication after DNA 
damage [28] led to a loss of interest in Ap4A as a possible contributor to replication control.  However, 
the recently recognized ability of small, highly phosphorylated molecules such as ppGpp (in bacteria) [29, 
30] and inositol pyrophosphates (in mammalian cells) [31, 32] to directly regulate aspects of DNA 
replication and repair suggest that a re-examination of the role of Ap4A in these processes is warranted.  
We now show here that non-cytotoxic doses of certain DNA damaging agents increase Ap4A to 
concentrations that can inhibit the initiation of DNA replication in a mammalian cell-free system and 
provide some pointers to the mechanism underlying this increase and its function. In addition, we 
demonstrate the accumulation in vivo of previously undetected ADP-ribosylated derivatives of Ap4A in 
response to DNA damage. 
 
 
2.  Materials and Methods 
 
2.1 Cell culture and maintenance  
 
Cell lines used for Ap4A measurements were AA8, EM9 and EM7 [33], H9T3-7-1 [34], NM3 [35], 
XR-1 and CHO-K1 Chinese hamster (CHO) cells [36], wild type (wt) and Xrcc1-/- and Parp1-/- mouse 
embryo fibroblasts (MEFs) [37], PF20 (wt) and PFL13-Lig1-/- MEFs [38], Cre4 (wt) and Cre4/2491#6 
(Lig3-/-) MEFs [39], and HeLa, FD105-M20 and FD105-M21 human cells [40]. These were cultured as 
previously described [35] with minor modifications.  Briefly, cells were maintained at 37°C in 5% (v/v) 
CO2/air in Dulbecco’s modified Eagle’s media (DMEM, Sigma), supplemented with 10% (v/v) foetal 
bovine serum (Autogene-Bioclear), 1% (v/v) non-essential amino acids, 100 µg mL-1 penicillin-
streptomycin (Sigma). Cre4/2491#6 (Lig3-/-) MEFs were also supplemented with 50 µg mL-1 uridine [39]. 
For subculture, cells approaching confluence were washed with 10 mL PBS then removed using 10 mL 
0.12% (w/v) trypsin, 0.008% (w/v) EDTA. Trypsinized cells were then added to 10 mL medium and 
centrifuged at 500 g for 5 min. Supernatants were removed and pelleted cells resuspended in fresh culture 
medium and reseeded at approximately 1 x 106 cells per 75 cm2 flask.  
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2.2 Growth inhibition assays 
 
Cells were grown in 100 mm dishes until 40-50% confluent, then treated with the stated 
concentrations of agents for 18 h.  They were then trypsinized, centrifuged, resuspended in fresh media 
and counted. For each MMC concentration, 5 x 105 cells were seeded into 75 cm2 culture flasks 
containing 15 mL growth medium and grown until the untreated control cultures reached confluence (72-
96 h). Cells were then trypsinized and counted using a hemocytometer. Average counts were normalized 
to the cell count of the untreated culture.  
 
2.3 Nucleotide extraction and assay 
 
This was based on our previous method [41].  For each determination, duplicate 100 mm dishes with 
~80% confluent cells were used to measure cell numbers and a further three dishes were used for 
nucleotide extractions and subsequent Ap4A assay.  Cells were washed with 10 mL PBS then 3 mL ice-
cold trichloroacetic acid (TCA) added to each dish. Cells were removed from the dishes with a rubber 
scraper then transferred to a cold glass tube. The dishes were rinsed with a further 2 mL TCA which was 
then combined with the extract. The 5 mL combined extract was incubated for 15 min at 4°C then 
neutralized by adding 5 mL 0.6 M tri-N-octylamine in 1, 1, 2-trichlorotrifluoroethane and shaking 
intermittently for 5 min.  Following centrifugation at 500 g for 5 min, 4.4 mL of the upper aqueous layer 
was removed, and 110 µL 2 M Tris-HCl, pH 8.5, 0.2 M magnesium acetate plus 2 µL (10 U) Antarctic 
phosphatase (New England Biolabs) added.  The mixture was incubated at 18 h at 37°C to degrade ATP 
completely. To collect and concentrate the resistant nucleotides, 100 µL 50% (v/v) DEAE-Sephacel 
(Sigma) in 20 mM Tris-HCl, pH 7.6, was added to the extract and the suspension mixed on a rotating 
platform for 30 min. This was then centrifuged at 12000 g for 1 min, the supernatant removed and the 
pellet washed with 2 mL water. Bound nucleotides were eluted by incubating the pellet with 0.5 mL 1.0 
M triethylammonium bicarbonate (TEAB, pH 8.5) for 5 min with shaking. The suspension was then 
centrifuged for 1 min at 12000 g and the supernatant collected. The elution step was repeated and the 
combined supernatants vacuum-dried for 2 h at 70°C. The dried nucleotide extracts were finally dissolved 
in 120 µL assay buffer (25 mM HEPES-NaOH, pH 7.8, 5 mM magnesium acetate).  To remove any 
residual ATP, 2 µL (10 U) Antarctic phosphatase was added and the tubes incubated at 37°C for 18 h, 
followed by further incubation at 65°C for 15 min to denature the phosphatase. Duplicate 10 µL aliquots 
were each mixed with 61 µL assay buffer and 50 µL BacTiter-Glo (Promega) and the background 
luminescence recorded in a Berthhold 9507 luminometer at room temperature.  Finally, 225 ng 
recombinant human NUDT2 Ap4A hydrolase [42] was added and the change in luminescence due to 
released ATP recorded. 
 
2.4 Analysis of cell extracts by HPLC 
 
Eight 100 mm dishes of cells were grown to 80% confluence and nucleotides extracted as described 
above. The vacuum-dried samples were each redissolved in 30 µL 1.0 M TEAB (pH 7.5), combined into 
a single tube and dried again at 70°C for 2 h. The sample was then redissolved in 21 mM ammonium 
bicarbonate, pH 9.6, and applied to a MonoQ column (GE Healthcare) equilibrated with 21 mM 
ammonium bicarbonate, pH 9.6. Nucleotides were eluted with a linear gradient of increasing ionic 
strength from 21 mM to 0.7 M ammonium bicarbonate, pH 9.6, over a total volume of 20 mL at a flow 
rate of 0.5 mL min-1.  Fractions (0.5 mL) were vacuum-dried at 70°C for 2 h, redissolved in 0.5 mL water, 
dried again, then finally redissolved in 60 µL assay buffer and the Ap4A content measured as described 
above. 
 
2.5 Synthesis of ADP-ribosylated Ap4A  
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ADP-ribosylated-Ap4A (ADPR-Ap4A) was synthesized using poly(ADP-ribose) polymerase 1 (PARP-
1) according to a previously published method [43].  The reaction (50 µL) contained 25 mM Tris-HCl, pH 
8.0, 1 mM DTT, 100 µM Ap4A, 25 µM NAD+, 5 µg histone H1 (Calbiochem), 10 µg PARP active DNA 
(R&D Systems) and 20 µg recombinant PARP-1-HSA enzyme (Trevigen). Reactions were incubated for 
18 h at 25°C and then the enzyme was deactivated by incubating for 10 min at 95°C followed by 
centrifugation for 10 min at 9000 g. The supernatant was removed and stored until further analysis. 
 
2.6 Cell-free DNA replication  
 
HeLa and mouse 3T3 cells were cultured in Dulbecco’s modified Eagles Media (D-MEM), 10% (v/v) 
foetal calf serum and penicillin/streptomycin/glutamine (all Gibco).  3T3 cells were synchronized in G0 
by contact inhibition and serum depletion followed by release into fresh media [44].  Late G1-phase and 
S-phase nuclei and S-phase extracts were prepared as described [44-46]. To assess replication initiation or 
elongation, 5×104 late G1- or S-phase 3T3 nuclei were mixed as appropriate with 10 µL of S-phase HeLa 
extract (supplemented with energy regenerating system, dNTPs and biotinylated dUTP) plus the 
nucleotide under test at 20 µM. Reactions were incubated at 37°C for 60 min, and biotin-labelled nascent 
DNA visualized by fluorescence microscopy after detection with streptavidin-Alexa Fluor 555 (Life 
Technologies) and counterstained with Hoechst 33258. The proportion of labelled nuclei was quantified 
by inspection at 1000× magnification, and all nuclei with discrete replication foci or intense uniform 
labelling were scored positive as previously described [45].  
 
2.7 siRNA knockdown 
 
Dharmacon ON TARGET plus siRNAs (single or pooled) were designed by and purchased from 
Thermo Scientific. Scrambled and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) siRNAs were 
routinely used as controls.  The lyophilized RNAs were re-suspended in RNase-free water at 10 pmol/µL 
and stored at -80°C until use. For siRNA knockdown, cells were grown to approximately 40 % 
confluence in 100 mm dishes. Prior to transfection, 300 pmol siRNA and 30 µL Dharmafect 1 (Thermo) 
were diluted separately in 500 µL serum-free DMEM and incubated at room temperature for 5 min then 
mixed together and incubated for a further 20 min to allow complex formation. Complexes were then 
added to cells and incubation carried out for 24-48 h.  Following incubation either nucleotides (for Ap4A 
assay, as above) or RNA (for measuring knockdown efficiency) were extracted from parallel cultures.  
RNA extraction was performed using a Qiagen RNeasy mini kit with QIAshredder and cDNA was 
synthesized using a Bioline Tetro cDNA synthesis kit, both according to the manufacturer’s instructions. 
The cDNA was then quantitated by PCR using Maxima SYBR Green master mix (Thermo) and a 
StepOnePlus™ Real Time PCR system (Applied Biosystems). The 2-∆∆Ct method was used to determine 
relative transcript levels [47]. No significant difference was found in efficiency between single and 
pooled RNAs.   
 
3.  Results 
 
3.1 Ap4A responds to DNA damage 
 
In order to determine whether intracellular Ap4A is increased in response to sublethal DNA damage, 
Chinese hamster AA8 cells, mouse embryo fibroblasts (MEFs) and HeLa cells were treated with low 
levels of the DNA cross-linking agent, mitomycin C (MMC).  MMC was chosen as the effect of cross-
linking agents on the level of Ap4A has not been studied before and as it is very effective at delaying the 
overall progress of DNA replication [48].  The growth inhibition curves in Fig. 2a showed no inhibition 
of the growth of AA8 and MEF cells up to a dose of 100 nM, although HeLa cells were more sensitive.  
Fig. 2(b-d) shows the dose-dependent increase in Ap4A in all three cell lines.  Untreated AA8 (Fig. 2b) 
and HeLa (Fig. 2c) cells had a very similar background level of Ap4A of 0.6-0.7 pmol/106 cells, consistent 
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with previous measurements [49], and both showed a 7–8-fold increase after treatment with 100 nM 
MMC. MEFs (Fig. 2d) consistently had a lower background level of about 0.1 pmol/106 cells but showed 
a similar (9-fold) increase after 100 nM MMC.  Treatment of AA8 cells with another DNA cross-linker 
1,2,3,4-diepoxybutane (DEB) led to a somewhat lower, 3-fold increase at a dose of 10 µM which resulted 
in 35% growth inhibition (Fig. 3).  Given a typical mammalian cell volume of 2000 µm3, an Ap4A content 
of 1 pmol/106 cells equates roughly to an intracellular concentration of 0.5 µM if uniformly distributed.  
These data indicate that a significant increase in intracellular Ap4A occurs after sublethal DNA damage 
and so support the view that this is a biologically significant response. 
This conclusion is confirmed by measurements of Ap4A in viable mutant cell lines that lack various 
DNA repair proteins and which contain higher than normal levels of endogenous DNA lesions.  XRCC1 
is an important scaffolding protein for DNA repair complexes [50, 51].  EM9 and EM7 cells are 
independent derivatives of AA8 that lack functional XRCC1 [52]. Both these lines have greatly elevated 
(up to 14-fold) Ap4A in the absence of exogenous DNA-damaging agents (Table 1).  The normal level of 
Ap4A is restored in EM9 cells expressing full-length human XRCC1 (H9T3-7-1 cells), showing that the 
increase is specifically due to the loss of XRCC1. MEFs lacking XRCC1 or PARP-1 also show elevated 
Ap4A (4- and 9-fold respectively) as do Chinese hamster cells deficient in the DNA ligase IV accessory 
protein XRCC4 [53] (XR-1, 2.7-fold) or the Fanconi anemia protein FANCG [35] (NM3, 2.7-fold).  
Human FD105 cells, derived from an individual with Ataxia with Oculomotor Apraxia type 1 (AOA1) 
and thus lacking aprataxin [54, 55], show a 5.7-fold increase.  Thus, elevated Ap4A is not associated with 
lethal stress but with tolerable levels of DNA damage. 
The related nucleotide Ap3A has been reported to be the major ligand of the FHIT tumour suppressor 
protein, which may have a role in the DNA damage response [19, 56].  So, in order to determine whether 
Ap3A responded to DNA damage in a similar manner, it was separately measured in a coupled 
luminometric assay [57].  No increase in Ap3A was found either after DNA damage or, for example, in 
EM9 cells (2.98 ± 0.32 pmol/106 cells, n=3) compared to 3.05 ± 0.27 pmol/106 cells (n=3) in AA8 cells.  
  
3.2 Enzymology of Ap4A generation in vivo 
 
Various enzymes have the ability to synthesize Ap4A and several of these, principally the aminoacyl-
tRNA synthetases, are thought to contribute to the background level of Ap4A found in all cells [14-16].  
Less is known about the enzymes responsible for stress-induced increases in Ap4A but within the context 
of DNA replication and repair, DNA ligases are likely candidates and have been proposed to fulfil this 
role [2]. These enzymes synthesize Ap4A by transfer of AMP from the enzyme-adenylate intermediate to 
an ATP acceptor [15, 58], an activity that is inhibited by DNA-binding [2].  So far, Lig III is the only 
mammalian ligase shown to synthesize Ap4A in vitro [2]. We found that the Lig I-specific inhibitor, L82, 
which prevents DNA-binding but not adenylation activity [59], caused only a slight, 1.3-fold increase in 
the level of Ap4A in AA8 cells treated for 18 h (0.75 pmol/106 treated cells  vs. 0.57 pmol/106 untreated 
cells, n = 4) whereas the Lig III inhibitor L67, which acts by a similar mechanism, led to a 5-fold increase 
in Ap4A to 2.72 pmol/106 cells, suggesting that Lig III may synthesize Ap4A in vivo when prevented from 
associating with DNA even in the absence of DNA damage. 
To investigate this further, we examined the levels and MMC-inducibility of Ap4A in Lig 1-/- and Lig 
3-/- knockout MEFs on the assumption that knockout of the responsible enzyme would prevent any MMC-
induced increase in Ap4A.  As previously observed, wild type PF20 and Cre4 MEFs had low levels of 
Ap4A (0.12 – 0.15 pmol/106 cells).  Treatment of PF20 cells with 100 nM MMC increased this level 17-
fold to 2.60 pmol/106 cells as expected (Table 2).  Deletion of Lig I (PFL13) caused a slight, 1.6-fold 
increase in background Ap4A but had no effect on the level reached after treatment with MMC (2.57 
pmol/106 cells), indicating that Lig I could not have been responsible for this increase. Cre4 MEFs were 
unusually resistant to MMC, only displaying a 2-fold increase after MMC treatment; however, no 
significant increase was observed in the Lig 3-/- knockout derivative Cre4/2491#6 after treatment with 
MMC, a condition that leads to a very large increase when combined with depletion of other DNA repair 
proteins (e.g. data in Table 3). The higher background level of Ap4A in Cre4/2491#6 cells compared to 
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wild type Cre4 suggests that the systems responsible for background and MMC-induced levels are not 
necessarily the same.  Moreover, there is evidence that DNA ligases can substitute for one another in 
ligation reactions [60-62] and the same may be true in relation to Ap4A synthesis in ligase knockout cells.  
Nevertheless, these results implicate Lig III as the most likely, if not sole ligase, contributing to MMC-
enhanced Ap4A synthesis. 
With regard to possible alternative systems, aminoacyl-tRNA synthetases (ARS), some of which are 
known to exist in nuclei [63], synthesize Ap4A in vitro by adenylation of ATP by an aminoacyl-AMP, 
with LysRS being one of the most efficient [64].  LysRS has been implicated in transcription factor 
activation by synthesizing Ap4A, which then disrupts the interactions between MITF and USF2 and the 
inhibitory Hint1 protein [13, 65].  Due to its unique ability to synthesize Ap4A in the absence of glycine 
by direct adenylyl transfer from one ATP to another, GlyRS has been proposed to be of particular 
importance in Ap4A homeostasis [66] and has been found loosely associated with protein complexes 
containing DNA polymerase-α [67].  Therefore, the effect of siRNA knockdown of LysRS and GlyRS 
expression in EM9 cells was studied. Rather than eliminating it, the already high level of Ap4A in EM9 
cells (4.06 pmol/106 cells in this experiment) was actually increased a further 3.7–3.8-fold by knockdown 
of either ARS (Table 3) possibly as a general response to the suppression of protein synthesis.  Thus, 
these results do not support a role for LysRS or GlyRS in generating the high level of Ap4A in EM9 cells. 
Another mechanism by which Ap4A could be increased after DNA damage is through suppression of 
the activity of a hydrolytic activity such as the NUDT2 Ap4A hydrolase [17].  However, we have found 
no significant difference in the activity of NUDT2 between AA8 and EM9 cells when cell extracts were 
subjected to gel filtration chromatography and assayed for NUDT2 activity in the 16-20 kDa region or 
when AA8 cells were treated with MMC (Fig. 4).  Nevertheless, normal NUDT2 expression does appear 
to limit the extent of Ap4A accumulation after DNA damage.  Significantly higher levels of Ap4A were 
found in EM9 cells after siRNA knockdown of NUDT2 — a 2.5-fold increase from 4.06 to 9.93 pmol/106 
cells in EM9 cells alone and a large 16-fold increase to 64 pmol/106 cells after MMC treatment (Table 3). 
Similar results were found with AA8 cells, although the differences were less marked due to the 
unexplained lower level of knockdown consistently found with AA8 compared to EM9 cells.  
Aprataxin, whose major function is to deadenylate abortive DNA ligation intermediates [54], 
particularly those arising through ribonucleotide excision repair [68], also has a limited ability to degrade 
Ap4A [20].  We have found a 6-fold increase in Ap4A in the mutant APTX-/- human cell line FD105-M20 
compared to FD105-M21 cells, which have been corrected by APTX expression [40] (Table 1), while 
knockdown of aprataxin expression in EM9 cells led to an 8-fold increase to 31.4 pmol/106 cells (Table 3).  
APTX knockdown also greatly enhanced the MMC-induced increase in AA8 cells from 3.9 to 10.6 
pmol/106 cells despite the limited reduction in expression.  However, it is not clear whether the loss of 
APTX-mediated Ap4A hydrolysis is directly responsible for the increase in Ap4A or whether this is due to 
Lig III-mediated Ap4A synthesis in response to an increased level of unrepaired strand breaks in APTX-
deficient cells.  
Note that none of the findings reported in Table 3 appear to be due to off-target or non-specific effects 
of the procedure as control data obtained using either scrambled or GAPDH siRNAs were never 
significantly different from those obtained without RNA addition.  
 
 
3.3 Ap4A is ADP-ribosylated in vivo 
 
The assay used to measure Ap4A relies on the specificity of the NUDT2 Ap4A hydrolase, which 
generates ATP from Ap4A [57].  NUDT2 would, however, also generate ATP from Ap5A and Ap6A, 
although neither of these nucleotides has even been reported in typical mammalian cells — they appear to 
be confined to certain excretory granules, such as adrenal chromaffin granules and platelet dense granules 
[2].  Nevertheless, extracts of AA8 and EM9 cells were subjected to ion-exchange chromatography to 
investigate further the nucleotide specificity of the response.  Surprisingly, in addition to a peak of Ap4A 
(peak 1), a second major (peak 2) and third minor peak (peak 3) that responded to the Ap4A assay were 
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found in EM9 extracts (Fig. 5c), neither of which co-chromatographed with Ap5A or Ap6A standards (Fig. 
5a).  The first peak was also seen in AA8 extracts, although relative to Ap4A it was very much smaller 
than that seen in EM9 cells (Fig. 5b); however they both increased significantly along with Ap4A after 
MMC treatment (Fig. 5d).  Thus, these additional species appear to respond strongly to DNA damage. 
It is known that Ap4A can be ADP-ribosylated in vitro by PARP1 to produce derivatives with multiple 
ADP-ribosyl units [43, 69], but such compounds have never been detected in vivo.  So, in order to 
determine whether peaks 2 and 3 might represent ADP-ribosylated derivatives, mono- and di-ADP-
ribosylated Ap4A (ADPR-Ap4A) were synthesized according to published procedures [43]. These 
synthetic compounds were authenticated by mass spectrometry (m/z = 1371.64 and 1918.75 respectively) 
and found to co-chromatograph with peaks 2 and 3 respectively (Fig. 6a).  Furthermore, when EM9 cells 
were treated in vivo with the PARP inhibitor KU-0058948 [70], the subsequent dinucleotide extract had a 
greatly reduced peak 2 and no peak 3 (Fig. 6b, compare to Fig. 5c), suggesting that a KU0058948-
sensitive PARP was involved in their generation.  Furthermore, when an EM9 extract was treated in vitro 
with poly(ADP-ribose) glycohydrolase (PARG) and then chromatographed, peaks 2 and 3 were abolished 
and the Ap4A peak increased, indicating a release of assayable Ap4A from ADP-ribosylated species by 
removal of the ADP-ribose (Fig. 6c, compare to Fig. 5c).  Finally, treatment of EM9 cells in vivo with the 
PARG inhibitor gallotannin [71] increased peaks 2 and 3, especially peak 3, at the expense of Ap4A (Fig. 
6d).  Taken together, these results clearly show that survivable DNA damage leads to an increase in the 
level of Ap4A and the appearance of its mono- and di-ADP-ribosylated derivatives (Fig. 1b).  So far we 
have not detected any longer poly(ADP-ribosyl)ated species in vivo. 
KU-0058948 is a specific inhibitor of PARP-1 and PARP-2, being one to three orders of magnitude 
more effective against these enzymes compared to other ADP-ribosyltransferases tested [70].  Therefore, 
the data in Fig. 6b, in which KU-0058948 led to a dramatic drop in the (mono + di)ADPR-Ap4A:Ap4A 
ratio in EM9 cells from 1.45 to 0.045 (equivalent to a 97% reduction in the ADP-ribosylated species), 
would suggest that one of these PARPs is responsible for the ADP-ribosylation of Ap4A. To investigate 
this further, the ADPR-Ap4A:Ap4A ratio was measured in Parp1-/- knockout MEFs after treatment with 
100 nM MMC.  This ratio was 0.19 in the knockouts compared to 0.33 in the wild type cells, indicating a 
40% decrease in ADPR-Ap4A in the absence of PARP-1 (Table 4).  The ratio was further reduced to 0.12 
when PARP2 expression was knocked down by siRNA in the Parp1-/- knockout MEFs.  The ADPR-
Ap4A:Ap4A ratio was used to quantify the results because of the increase in the absolute levels of both 
nucleotides in PARP-deficient cells due to retarded repair of endogenous DNA damage.  Thus it appears 
that both PARP1 and PARP2 are able to ADP-ribosylate Ap4A although their relative contributions in 
wild type cells is harder to assess.  As with DNA ligases, there is evidence that PARP1 and PARP2 may 
exhibit some functional redundancy in DNA repair processes [72]. 
 
3.4 Ap4A inhibits the initiation of DNA replication  
 
It has previously been suggested, without supporting evidence, that elevated Ap4A might act as a 
stress-induced alarmone to either inhibit DNA replication to allow repair to occur or to promote 
replication fork restart [2-4, 21].  Therefore, in order to assess whether Ap4A could inhibit DNA 
replication, we utilized an in vitro DNA replication assay that has previously been used to recapitulate 
either the elongation phase or the initiation phase of DNA replication using defined synchronized nuclei 
and cytosolic extracts [46, 73-75]. Incubation of a G1 extract and late G1 nuclei [44] reveals the 
population of cells currently in S-phase due to asynchrony (Fig. 7a, 12 %); initiation competent nuclei are 
identified by addition of a cytosolic S-phase extract that increases the number of S-phase nuclei to 45% of 
the population (Fig. 7a). Using this approach to test whether Ap4A could affect initiation, elongation, or 
both, G1 nuclei and S-phase extracts were initially incubated with 20 µM Ap4A.  This revealed a marked 
reduction in the number of nuclei undergoing DNA replication (22%, Fig. 7a) suggesting that Ap4A 
inhibits some aspect of this process. This result could conceptually be caused by a failure of cells to 
initiate replication de novo or via inhibition of the elongation phase. 
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Therefore, to assess whether Ap4A affects the elongation phase, an S-phase population of cells was 
produced by a double thymidine block [46, 73-75]. Under these conditions, 100% of nuclei were in S-
phase in control reactions and addition of up to 1 mM Ap4A did not reduce the number of replicating 
nuclei, suggesting that Ap4A does not inhibit DNA replication elongation (Fig. 7b).  This contrasts with 
reactions that recapitulate the latter stages of G1 phase and monitor initiation of DNA replication using 
replication-licensed late G1-phase nuclei and S-phase cytosolic extracts [44, 46, 73]. Under these 
conditions, Ap4A caused a marked, dose-dependent reduction in DNA replication maximizing at 70-80% 
inhibition at 20 µM Ap4A that was maintained up to 1 mM Ap4A (Fig. 7c). To ensure that this effect was 
specific to Ap4A, reactions were also performed with Ap3A, Ap5A, Gp4G and ADPR-Ap4A, which 
revealed no significant effect of these Ap4A analogs at 20 µM (Fig. 7d).  Even at 0.8 µM Ap4A (approx. 
1.6 pmol/106 cells) inhibition was significant at 40%. The inhibitory concentration of Ap4A seen here is 
consistent with that found after induction with sub-lethal doses of DNA crosslinking agents, suggesting 
that damage-induced Ap4A could retard the initiation of DNA replication at physiologically relevant 
levels.  As cells, e.g. EM9, are perfectly able grow in the presence of elevated Ap4A this inhibition must 




4.  Discussion 
 
Previous DNA damaging agents shown to increase intracellular Ap4A in mammalian cells have 
included N-methyl-N′-nitro-N-nitrosoguanidine (MNNG), bleomycin, and either ultraviolet (UV) light or 
4-nitroquinoline-N-oxide (4NQO) in the presence of arabinosylcytosine (araC) [5, 6, 22]. Since Ap4A did 
not increase in incision-defective xeroderma pigmentosum complementation group A cells treated with 
UV or 4NQO plus araC, it was suggested that Ap4A accumulated in response to direct or indirect DNA 
strand breaks [22].  The response to DNA cross-linking agents has not been studied before.  Here we have 
shown that non-cytotoxic levels of mitomycin C and diepoxybutane are highly effective at increasing 
Ap4A.  As the repair of these lesions will also lead to indirect strand breaks, these data along with the 
enhanced levels found in cells lacking XRCC1, PARP1 and FANCG, in which endogenous strand breaks 
are likely to have a prolonged half-life, would support the role of strand breaks as at least one causative 
factor. However, interstrand crosslinks may themselves be a more potent stimulus, which would explain 
why Ap4A increases significantly at low doses of MMC compared to the more toxic doses of 
monofunctional alkylating agents previously used.  The higher efficacy of MMC compared to DEB may 
be due to the ability of MMC crosslinks to block replication with minimal perturbation of the DNA 
structure and their consequent poor removal by nucleotide excision repair mechanisms outside S-phase 
[76].  Thus, increased Ap4A is not necessarily associated with excessive stress and cell death, as has 
previously been suggested, and so this response is likely to be biologically relevant. 
Although ARSs are generally held to be major contributors to the intracellular Ap4A pool, GlyRS and 
LysRS at least do not seem to be responsible for the DNA damage-induced increases observed here and 
we have no a priori reason to implicate other members of this ligase family.  Knockdown of GlyRS and 
LysRS expression led in fact to an unexpected increase in Ap4A in EM9 cells.  LysRS has been shown to 
be responsible for the stimulation of Ap4A synthesis by immune complexes in mast cells and its 
knockdown in that case completely eliminated Ap4A induction [13].  Thus, the facts that LysRS-mediated 
Ap4A synthesis can be abolished by siRNA knockdown but that knockdown does not eliminate DNA 
damage-mediated Ap4A synthesis would support our contention that ARSs are not responsible for the 
DNA damage-mediated response.  ARS knockdown is known to cause translational suppression [77] and 
this may have served as the stimulus for increased Ap4A synthesis by other synthetases independently of 
DNA damage.  Although data are lacking in eukaryotes, Ap4A has been proposed as a signal for 
translational incapacity in E. coli [78] and the increases in ARS knockdown cells are consistent with this 
additional role for Ap4A.  One other ARS of special interest in nuclei is TrpRS as it has been found 
associated with protein complexes containing DNA polymerase-α and the unidentified Ap4A-binding 
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protein [67] and with DNA-dependent protein kinase and PARP-1 [79].  However, TrpRS is unusual in 
being only able to synthesize Ap3A, and not Ap4A [80, 81], and so could not be responsible for the 
observed increases.  Instead, our results would favor a role for DNA ligase III as the main enzyme 
responsible for the synthesis of DNA damage-induced Ap4A. 
Although our data support stimulation of Ap4A synthesis as a major cause of increased Ap4A, an 
additional role for decreased degradation cannot be excluded.  The association of APTX with XRCC1, 
PARP1 and XRCC4 in DNA repair complexes [82, 83] makes it an ideal candidate for such a role and we 
have found that cells from individuals with AOA1, which lack functional APTX, do have significantly 
increased Ap4A and that APTX knockdown increases Ap4A in hamster cells.  However, further analysis 
using specific APTX mutants will be required to determine whether this is caused by loss of the Ap4A 
hydrolase activity per se rather than a secondary effect due to persistent DNA damage in APTX– cells.  
Alterations in the activity of NUDT2, the major intracellular Ap4A hydrolase, do not appear to be 
responsible for DNA damage-induced accumulation of Ap4A, although the enzyme does limit the extent 
of the increase and may prevent harmful levels from being reached.  At high levels, Ap4A can inhibit the 
activity of several protein kinases, something that could prove cytotoxic [2].  Interestingly, 
overexpression of NUDT2 has been correlated with a slight increase in cellular proliferation rate while 
siRNA-mediated reduction in NUDT2 expression has been associated with slower proliferation [84].  
Although the level of Ap4A was not measured in that study, these results are consistent with the inhibitory 
effect of Ap4A on DNA replication initiation.  Another protein that can hydrolyze Ap4A is the Fhit tumor 
suppressor protein, although it prefers Ap3A as a substrate [19]; however, Fhit appears to have no role in 
controlling the level of Ap4A in vivo as the level of Ap4A is known to be unchanged in Fhit-deficient cells 
[41]. 
The hypothesized role for Ap4A as an inhibitor of DNA replication is directly supported for the first 
time by our finding that it inhibits replication in a well-characterized cell-free system comprising G1 
nuclei and essential cytoplasmic components [44-46]. In contrast, elongation at previously initiated 
replication forks in S-phase nuclei appears to be unaffected.  Together, these results are consistent with a 
specific effect on initiation. However, without further experimentation we cannot say at what point 
initiation is affected and whether this depends, for example, on the presence of endogenous DNA lesions; 
nor can we exclude an effect on elongation rates or other aspects of replication such as origin usage and 
inter-origin distance.  Nevertheless, the concentrations at which inhibition occurs are well within the 
range achieved in vivo.  Inhibition of origin initiation by Ap4A is consistent with the observations that (i) 
fewer new origins are initiated after MMS treatment of XRCC1-defective EM9 cells compared to cells 
complemented with XRCC1 [85] and (ii) MMC primarily reduces the abundance of replication forks but 
not rates of fork progression [48].  Whether the unidentified Ap4A-binding protein associated with DNA 
polymerase-α is involved in this inhibition remains to be determined.  However, it is interesting to note 
that transformation of the data in Fig.7b to fit a single rectangular hyperbola gave a good fit (R2 = 0.90) to 
a single site model with a Ki of 0.28±0.09 µM, a figure that agrees well with a previously measured Kd of 
0.15 µM for the HeLa cell Ap4A binding protein [23]. 
The combined PARP inhibitor and knockout data suggest that either or both of PARP1 and PARP2 are 
responsible for the ADP-ribosylation of Ap4A in vivo.  Of the many known ADP-ribosyltransferases only 
PARP1, PARP2 and PARP5 (tankyrase) isoforms are known to synthesize ADP-ribose oligomers [86], so 
the presence of di(ADPR)-Ap4A in cell extracts would suggest that none of the many mono-ADP-
ribosyltransferases, including PARP3, is responsible.  Furthermore, tankyrase is insensitive to KU-
0058948 and so can be discounted [70].  However, the function of the mono- and di(ADPR)-Ap4A 
species is still not clear. One possibility is that they serve to inactivate the inhibitory function of Ap4A by 
preventing it from binding to its target(s) and so permit the rapid resumption of DNA replication initiation 
following lesion repair.  One previous study showed that the PARP inhibitor 3-aminobenzamide 
enhanced the 2-fold increase in Ap4A in HTC hepatoma cells caused by 200 µM MNNG by 100% and 
prevented its subsequent recovery to the basal level over a period of 5 hours [6].  This is consistent with 
an inactivating function for the ADP-ribosylation. Certainly, inhibition of initiation by Ap4A in vivo must 
be transient, as cells possessing high levels of Ap4A do proceed successfully into and through S-phase. 
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Interestingly, synthetic poly(ADP-ribosylated)Ap4A with an average chain length of 7.5 ADPR units has 
been shown to inhibit T-antigen-dependent DNA synthesis from an SV40 origin in vitro [87]; however, 
we have not detected species longer than di(ADPR)-Ap4A in vivo, so the biological significance of the 
longer inhibitory polymers remains unresolved. 
In conclusion, our results support Varshavsky’s original hypothesis that stalled replication complexes 
generate a low-molecular-weight alarmone signal, Ap4A, that aids survival after DNA damage [3, 4].  We 
propose that DNA ligase III synthesizes Ap4A when prevented from accessing ligation sites in the DNA 
through changes in protein-protein interactions involving XRCC1, PARP1, APTX and other components. 
Changes in APTX hydrolytic activity may further enhance the increase in Ap4A. The resulting Ap4A then 
binds to one or more target proteins and temporarily delays the initiation of new replicons.  This would 
help prevent further replication forks from encountering DNA lesions. One possible advantage of 
damage-generated Ap4A is that it could act as a diffusible signal and so exert its protective effect at 
secondary sites close to the stalled replication apparatus. ADP-ribosylation of the Ap4A may then serve to 
rapidly terminate its inhibitory function. Although a number of questions remain to be answered, we hope 
that these findings will serve as a platform for renewed interest in Ap4A as an important inducible ligand 
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Fig. 1.  Structures of (a) Ap4A and (b) ADP-ribosylated Ap4A derivatives; n=1, mono-ADPR-Ap4A; n=2, 
di-ADPR-Ap4A.  The position of the linkage between Ap4A and ADP-ribose has not been unequivocally 
established but is assumed based on the linkage between ADP-ribose units in poly(ADP-ribose) [77]. 
 
Fig. 2.  Effect of mitomycin C (MMC) on the growth of AA8, MEF and HeLa cells.  Cells were treated 
for 18 h with the indicated dose of MMC after which they were (a) counted and plated into 75 cm2 flasks 
to measure growth or (b-d) subjected to nucleotide extraction and Ap4A measurement as described in 
Materials and Methods. 
 
Fig. 3.  Effect of 1,2,3,4-diepoxybutane (DEB) on AA8 cells.  Cells were treated for 18 h with the 
indicated dose of DEB after which they were (a) counted and plated into 75 cm2 flasks to measure growth 
or (b) subjected to nucleotide extraction and Ap4A measurement as described in Materials and Methods. 
 
Fig. 4.  Activity of NUDT2 Ap4A hydrolase in (a) AA8 and EM9 cells and (b) AA8 cells treated with 100 
nM and 1 µM mitomycin C.  Chromatography is necessary to remove contaminating ATPases and 
phosphodiesterases that interfere with the assay.  Extracts of AA8 and EM9 cells were prepared and 2 mg 
soluble protein in 0.7 ml 50 mM Tris-HCl (pH 7.6), 200 mM NaCl, 1% (v/v) Igepal CA-630 applied and 
run at 1 mL min-1 on a 16 × 60 HiLoad Superdex 75 column in 50 mM Tris-HCl (pH 7.6), 200 mM NaCl.  
Fractions (1 mL) were collected and 20 µL assayed for NUDT2 Ap4A hydrolase activity.  The column 
was calibrated with molecular weight standards: (1) dextran blue (void volume), (2) BSA (67 kDa), (3) 
ovalbumin (43 kDa), (4) chymotrypsinogen A (25 kDa) and (5) ribonuclease A (13.7 kDa). 
 
Fig. 5.  High performance ion-exchange chromatography of cellular dinucleotide extracts.  Standards (a) 
and extracts of (b) AA8, (c) EM9 and (d) AA8 cells treated for 18 h with 100 nM MMC were subjected to 
hplc analysis and fractions assayed for Ap4A as described in Materials and Methods. 
 
Fig. 6.  High performance ion-exchange chromatography of dinucleotide preparations.  Samples were (a) 
50 µL of ADPR-Ap4A synthetic reaction prepared as described in Materials and Methods; (b) extract of 
EM9 cells grown in the presence of 0.1 µM KU0058948 for 18 h; (c) extract of EM9 cells incubated for 
18 h with 10 µg human PARG (Enzo Life Sciences); (d) extract of EM9 cells grown in the presence of 
100 µM gallotanin (Enzo) for 18 h. 
 
Fig. 7. Effect of Ap4A and related nucleotides on DNA replication in a cell-free DNA replication system. 
(a) Reconstitution of the initiation phase of DNA replication. G1 extract and G1 nuclei reveal the 
proportion of cells in S-phase in this population. Replication licensed nuclei that are initiation competent 
can be stimulated to enter S-phase by addition of S-phase cytosolic extracts (middle bar) and the effect of 
20 µM Ap4A on DNA replication (right bar) shows a reduction in the number of nuclei incorporating 
biotinylated-dUTP (b-dUTP). Further statistical analysis of the DNA replication activity after 
dinucleotide treatment was performed by one-way analysis of variance (ANOVA) using Tukey’s test 
post-hoc at 99.9% significance levels using IBM SPSS statistics 21 (*** = P<0.001).  (b) Increasing 
concentrations of Ap4A (0–1 mM) were incubated for 60 min with S-phase extract, S phase nuclei, b-
dUTP and % nuclei incorporating label determined. Data are means ± S.D., n =3.  (c) Increasing 
concentrations of Ap4A were incubated with S-phase extract, G1 nuclei, b-dUTP and the % nuclei 
incorporating label due to initiation of replication determined as previously described [73, 74, 76, 77].  
Data are means ± S.D., n =3. Inset, data as described in (c) and presented in an unscaled format. (d) 
Various dinucleotides (20 µM) were incubated for 60 min with S-phase extract, G1-phase nuclei, b-dUTP 
as in (c) and the % nuclei incorporating label determined. Data are means ± S.D., n =3. Further statistical 
analysis of the DNA replication activity after dinucleotide treatment was performed by one-way analysis 
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of variance (ANOVA) using Tukey’s test post-hoc at 99.9% significance levels using IBM SPSS statistics 
21 where *** = P<0.001. 
  















AA8 0.63 ± 0.07 6 
EM9 (Xrcc1-) 4.16 ± 0.30 6 
EM7 (Xrcc1-) 8.77 ± 0.84 3 
H9T3-7-1 (XRCC1-
corrected EM9) 
0.78 ± 0.06 4 
MEF wt 0.06 ± 0.01 6 
MEF Xrcc1-/- 0.24 ± 0.09 3 
MEF Parp1-/- 0.56 ± 0.06 3 
CHO-K1 (control for XR-
1) 
0.62 ± 0.08 3 
XR-1 (Xrcc4-) 1.73 ± 0.20 3 
NM3 (FANCG-) 2.98 ± 0.13 3 
NM3 (FANCG corrected) 1.10 ± 0.11 3 
FD105 M20 (APTX- ) 1.26 ± 0.29 3 
FD105 M21 (APTX 
corrected) 
0.22 ± 0.03 3 
 
 
a Cells were grown, extracted and Ap4A measured as described in Materials and Methods.  Results are 
means ± S.D.  
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Table 2. Intracellular level of Ap4A in DNA ligase-deficient MEFs with and without treatment with 100 









Ap4A (pmol/106 cells) 
PF20 (wt) -  0.15 ± 0.04  
PF20 (wt) +  2.60 ± 0.44  
PFL13 (Lig1-/-) - 0.25 ± 0.06  
PFL13 (Lig1-/-) +  2.57 ± 0.63  
Cre4 (wt) - 0.12 ± 0.02  
Cre4 (wt) + 0.27 ± 0.13 
Cre4/2491#6 (Lig3-/-) - 0.54 ± 0.27  
Cre4/2491#6 (Lig3-/-) + 0.58 ± 0.31 
  
a Cells were grown, extracted and Ap4A (including ADPR-Ap4A) measured as described in Materials and 
Methods. Results are mean ± S.D. (n = 3).  
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Table 3.  Effect of siRNA knockdown of the expression of potential Ap4A-metabolizing enzymes on the 










EM9 - 4.06 ± 0.66  
EM9 Scrambled 4.15 ± 0.25 
EM9 GAPDH 3.67 ± 0.11 
EM9 LysRS 14.81 ± 3.36 
EM9 GlyRS 15.42 ± 2.31 
EM9 NUDT2 9.93 ± 1.65 
EM9 APTX 31.39 ± 3.04 
AA8 - 0.63 ± 0.07 
AA8 Scrambled 0.56 ± 0.11 
AA8 GAPDH 0.90 ± 0.26 
AA8 NUDT2 0.66 ± 0.31 
AA8 APTX 1.18 ± 0.03 
EM9 + MMC - 17.08 ± 0.16 
EM9 + MMC GAPDH 14.60 ± 1.04 
EM9 + MMC NUDT2 64.19 ± 2.54 
EM9 + MMC APTX 43.62 ± 2.92 
AA8 + MMC - 3.92 ± 0.12 
AA8 + MMC GAPDH 3.49 ± 0.18 
AA8 + MMC NUDT2 4.67 ± 0.14 
AA8 + MMC APTX 10.56 ± 1.88 
 
aKnockdown was carried out and quantitated by RT-qPCR as described in Materials and Methods and 
was typically between 70 and 80% for EM9 cells and between 20 and 30% for AA8 cells. The levels of 
Ap4A include ADPR-Ap4A. When added, MMC was at 100 nM. Results are mean ± S.D. (n = 3). 
  






Table 4.  Roles of PARP1 and PARP2 in ADP-ribosylation of Ap4A in mouse embryo fibroblasts treated 















Parp1+/+ (wt) MEFs 0.261 0.086 0.33 
Parp1-/- MEFs 0.736 0.140 0.19 
Parp1-/- MEFs + PARP2 KD 3.63 0.44 0.12 
 
aThe degree of PARP2 knockdown measured by RT-qPCR was 74%.  Cell extracts were subjected to hplc 
and assay as described in Materials and Methods and the levels of Ap4A and ADPR-Ap4A summed in the 
relevant fractions.  Results are the means of two independent determinations. 
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